Details of the Drug
General Information of Drug (ID: DMFNQZS)
Drug Name |
2-(4-(methylamino)phenyl)benzo[d]thiazol-6-ol
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
2-(4-(methylamino)phenyl)benzo[d]thiazol-6-ol; 566169-93-5; UNII-K6396E6G8G; CHEMBL93124; K6396E6G8G; AK-87409; 2-[4'-(methylamino)phenyl]-6-hydroxybenzothiazole; Pittsburgh compound B unlabelled; 2-(4'-methylaminophenyl)-6-hydroxybenzothiazole; SCHEMBL912744; ZQAQXZBSGZUUNL-UHFFFAOYSA-N; MolPort-028-616-384; ZINC3816332; BDBM50129793; AKOS022184240; FC-3012; 4-methylamino-phenyl)-benzothiazol-6-ol; AJ-45711; PIB authentic (6-OH-BTA-1) free base; 2-(4-Methylamino-phenyl)-benzothiazol-6-ol
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 256.32 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | 3.9 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 2 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 2 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 4 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||